Keppra injection: the 1st and only 2nd generation injectable anticonvulsant
In the bag… without all the baggage:
No blood level monitoring required with Keppra
No loading dose required
No known clinically significant drug interactions
No reported incidence of purple glove syndrome in clinical studies
No special handling required for storage or vial
Levetiracetam (INN) is an anticonvulsant medication used to treat epilepsy. It is S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc.
Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain.
Levetiracetam has recently been approved in the United Kingdom as a monotherapy treatment for epilepsy. It is also used in veterinary medicine for similar purposes.
Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, autism, and anxiety disorder, but its most serious adverse effects are behavioral and its benefit-risk ratio in these conditions is not well understood.
